| Literature DB >> 30443360 |
Patricia Casino1,2,3, Roberto Gozalbo-Rovira4,5, Jesús Rodríguez-Díaz4,5, Sreedatta Banerjee6, Ariel Boutaud7, Vicente Rubio2,3, Billy G Hudson8,9,10,11,12,13,14, Juan Saus15, Javier Cervera2,3,4, Alberto Marina2,3.
Abstract
Basement membranes are extracellular structures of epithelia and endothelia that have collagen IV scaffolds of triple α-chain helical protomers that associate end-to-end, forming networks. The molecular mechanisms by which the noncollagenous C-terminal domains of α-chains direct the selection and assembly of the α1α2α1 and α3α4α5 hetero-oligomers found in vivo remain obscure. Autoantibodies against the noncollagenous domains of the α3α4α5 hexamer or mutations therein cause Goodpasture's or Alport's syndromes, respectively. To gain further insight into oligomer-assembly mechanisms as well as into Goodpasture's and Alport's syndromes, crystal structures of non-collagenous domains produced by recombinant methods were determined. The spontaneous formation of canonical homohexamers (dimers of trimers) of these domains of the α1, α3 and α5 chains was shown and the components of the Goodpasture's disease epitopes were viewed. Crystal structures of the α2 and α4 non-collagenous domains generated by recombinant methods were also determined. These domains spontaneously form homo-oligomers that deviate from the canonical architectures since they have a higher number of subunits (dimers of tetramers and of hexamers, respectively). Six flexible structural motifs largely explain the architectural variations. These findings provide insight into noncollagenous domain folding, while supporting the in vivo operation of extrinsic mechanisms for restricting the self-assembly of noncollagenous domains. Intriguingly, Alport's syndrome missense mutations concentrate within the core that nucleates the folding of the noncollagenous domain, suggesting that this syndrome, when owing to missense changes, is a folding disorder that is potentially amenable to pharmacochaperone therapy.Entities:
Keywords: (IV)NC1 hexamers; Alport’s syndrome; Goodpasture’s disease; collagen type IV; network assembly
Year: 2018 PMID: 30443360 PMCID: PMC6211539 DOI: 10.1107/S2052252518012459
Source DB: PubMed Journal: IUCrJ ISSN: 2052-2525 Impact factor: 4.769
Crystallographic data and refinement statistics for crystals of recombinant NC1 chains and their mixtures
Values in parentheses are for the highest resolution shell.
| α1NC1homo | α2NC1homo | α3NC1homo | α4NC1homo | α5NC1homo | α121NC1 | |
|---|---|---|---|---|---|---|
| Crystallization | ||||||
| Crystallization mixture | 1.4 | 22% polyvinylpyrrolidone K15, 0.1 | 16% PEG 3350, 0.2 | 6% PEG 3350, 0.2 | 20% PEG 8000, 0.2 | 10% PEG 8000, 0.2 |
| Additions for crystal harvesting | 15% sucrose, 7.5% ethylene glycol | None | PEG 3350 increased to 40% | Two-step graded increase to 40% PEG 3350 | PEG 8000 increased to 40% | PEG 8000 increased to 20% and 20% sucrose added |
| Data collection | ||||||
| Light source | ID23-2, ESRF | BL13, ALBA | ID23-1, ESRF | ID23-1, ESRF | ID14-1, ESRF | ID29, ESRF |
| Wavelength (Å) | 0.87 | 0.98 | 1.00 | 1.00 | 0.98 | 1.25 |
| Space group |
|
|
|
|
|
|
|
| 94.9, 127.1, 130.5 | 94.3, 94.3, 223 | 131.5, 131.5, 248.9 | 145.6, 167.6, 155.4 | 121.3, 121.3, 121.3 | 126.2, 126.2, 216.2 |
| α, β, γ (°) | 90, 90, 90 | 90, 90, 90 | 90, 90, 120 | 90, 90, 90 | 90, 90, 90 | 90, 90, 120 |
| Resolution (Å) | 57.12–1.80 (1.90–1.80) | 112.81–2.50 (2.64–2.50) | 65.76–2.70 (2.85–2.70) | 49.44–2.80 (2.95–2.80) | 60.63–1.85 (1.95–1.85) | 48.75–2.82 (2.97–2.82) |
|
| 7.6 (38.8) | 13.4 (168.8) | 8.4 (26.4) | 7.9 (33.6) | 10.0 (35.4) | 9.2 (36.7) |
|
| 4.8 (24.8) | 2.7 (33.3) | 6.9 (22.3) | 3.2 (13.1) | 4.9 (17.4) | 4.0 (16.6) |
| Mean | 10.7 (2.8) | 24.1 (2.4) | 11.2 (4.9) | 14.6 (5.6) | 12.1 (4.1) | 12.7 (3.6) |
| Completeness (%) | 98.2 (99.0) | 100 (100) | 98.4 (95.0) | 99.9 (100.0) | 99.3 (99.9) | 98.9 (99.8) |
| Multiplicity | 3.4 (3.3) | 25.2 (26.4) | 2.2 (2.1) | 7.3 (7.5) | 4.8 (4.8) | 5.4 (5.3) |
| Refinement | ||||||
| Resolution (Å) | 57.12–1.80 | 112.81–2.50 | 65.76–2.70 | 49.44–2.80 | 60.63–1.85 | 48.75–2.82 |
| No. of reflections | ||||||
| Total/unique | 479345/142960 | 456608/18124 | 96546/43361 | 341405/46979 | 125648/26393 | 258124/48121 |
| Unique | 68684/20928 | 68350/2593 | 12599/6111 | 51123/6783 | 18482/3812 | 36709/6976 |
|
| 17.6/19.9 | 24.6/27.9 | 16.3/17.6 | 23.2/28.0 | 18.5/19.0 | 14.1/18.4 |
| Protein chains | 6 | 2 | 8 | 6 | 1 | 6 |
| No. of atoms | ||||||
| Protein | 10612 | 2739 | 13891 | 9603 | 1764 | 10413 |
| Ligands/ions | 52 | 0 | 16 | 0 | 25 | 11 |
| Water | 789 | 55 | 232 | 67 | 116 | 141 |
|
| ||||||
| Protein | 18.5 | 63.7 | 26.6 | 56.9 | 12.9 | 65.5 |
| Ligands/ions | 24.6 | 0 | 27.1 | 0 | 20.7 | 65.3 |
| Water | 26.7 | 52.9 | 31.2 | 47.6 | 18.8 | 50.9 |
| R.m.s. deviations | ||||||
| Bond lengths (Å) | 0.009 | 0.008 | 0.008 | 0.009 | 0.009 | 0.009 |
| Bond angles (°) | 1.27 | 1.34 | 1.15 | 1.33 | 1.25 | 1.19 |
A single crystal was used for each structure.
Figure 1Crystal structure of α5NC1homo. (a) Cartoon representation of the crystal structure of recombinant α5NC1 formed by a hexamer composed of two trimers. Each trimer contains three subunits of α5NC1 coloured magenta/orange, cyan/pink and blue/yellow. (b) Cartoon representation of a subunit with a schematic representation of the N-subdomain (green) and C-subdomain (magenta) folds. The N-subdomain consists of β-sheets I (β1, β2, β5 and β10) and II (β3, β4, β6′, β7′, β8 and β9), while the C-subdomain consists of β-sheets I′ (β1′, β2′, β5′ and β10′) and II′ (β3′, β4′, β6, β7, β8′ and β9′). The scheme highlights the fact that β6 and β7 from another protomer (coloured blue) are swapped between the NC1 monomers, whereas β6′ and β7′ (coloured magenta) are swapped from the C-subdomain into the N-subdomain of the same subunit.
Figure 2Surface representations of the quaternary structures of the canonical hexameric α5NC1homo, α1NC1homo, α3NC1homo and α121NC1 and the noncanonical α2NC1homo and α4NC1homo organized as octamers and dodecamers, respectively. Each subunit in the assemblies is coloured differently. The top and middle rows show views in which the axis of highest molecular symmetry is vertical. In the bottom row this axis is perpendicular to the paper, allowing a view of the equatorial surface of the protomer.
Figure 3Structural comparisons of α2NC1α121, α2NC1homo and α4NC1homo. The same colour scheme is used in the three panels. (a) Comparison of the α2NC1 and α4NC1 subunits in these oligomers, highlighting the regions with the greatest conformational difference in comparison to α2NC1α121. Important structural motifs (SMs; see text) are labelled and coloured. Dashed lines represent highly disordered regions that are not visible in the crystal structures. (b) Cartoon representation of the structures of an α121NC1 protomer and the corresponding noncanonical α2NC1homo and α4NC1homo tetrameric and hexameric protomers. (c) Plot of r.m.s.d. deviation per Cα atom along the sequences between α2NC1α121 and α2NC1homo (top) and α4NC1homo (bottom). Dashed vertical lines enclose the structural motifs (identified with arrows) showing high r.m.s.d.s. The thick horizontal line (residues 196–210) indicates a lack of electron density.
Figure 4Hexamer stabilization through ion binding and potential sulfilimine-bond sites. (a) The chloride ion ClA (red) interacts with the main-chain amino groups of Lβ7β8 (ClA motif) and a water molecule (blue) in two opposing monomers. (b) The chloride ion ClB (green) binds to residues of flexible regions from three opposing monomers in the ClB motif (Ala186 in Lβ7′β8′ and Tyr189 in β8′) and Asn66 in SM2. (c) Semi-transparent surface representation (enclosing a cartoon representation) of the equatorial view of the protomer in the canonical α1NC1homo hexamer indicating the six ClA ions (red) and six ClB ions (green) at the interface between the protomers in the hexamer. In addition, the six interfacial Met93 residues (yellow) and the six Lys211 residues (blue), three from the shown protomer and the other three from the top protomer (not shown), are also indicated to stress their proximity, which allows easy sulfilimine-bond formation. These residues and the ClA and ClB ions are also shown in the view of the complete α1NC1homo hexamer illustrated on the right. (d) Zoom on the flexible Lβ8β9 (SM3) and β9′ (SM3′) regions of opposing monomers, highlighting the closeness of the Met93 and Lys211 residues of each region, respectively. A mere rotamer change of Lys211 would place it in position for the formation of a sulfilimine bridge with Met93.
Figure 5Structural bases of Alport’s and Goodpasture’s syndromes. (a) Goodpasture’s epitopes EA (left) and EB (right) as seen in the superimposed structures of subunits of α3NC1homo (cyan or blue) and α5NC1homo (orange or green). The same colour code is used for the amino-acid side chains (except for invariant residues, which are shown in black). (b) Structure-assisted sequence alignment of the α1–5NC1 chains. Arrows indicate β-strands and cylinders indicate α-helices. β-Strands of the I/I′ and II/II′ sheets are coloured light pink and light blue, respectively. Blue rectangles enclose flexible regions and Cl motifs (labelled), horizontal magenta lines mark the EA and EB epitopes (also labelled) and coloured shadowing indicates the residues reported to host missense mutations in Alport’s syndrome. (c) Alport’s syndrome missense mutations (listed in Supplementary Table S5) are mapped onto the structure of an α5NC1 subunit. Yellow spheres represent mutations in this chain, while superimposed mutations of α3NC1 and α4NC1 are coloured orange and green. β-Sheets I/I′ and II/II′ are coloured light pink and light blue, respectively, EA and EB are shown in magenta and flexible SM regions and Cl motifs are presented in deep blue.
Figure 6Proposed model for canonical hexamer assembly. Individual monomers (a) start to nucleate a protomer via β-sheets I/I′ (b). Next, the SM1/1′ and SM2/SM2′ flexible regions from β-sheets II/II′ are stabilized in the nascent protomer, resulting in favoured additional intersubunit interactions within the protomer (c). Final stabilization is attained with the proper folding of SM3′ and of the ClA and ClB motifs that allow the binding of chloride ions (green spheres) (d). The two protomers in the hexamer are now ready to be joined by sulfilimine bonds (red lines).